AstraZeneca Return on Investment 2012-2025 | AZN

Current and historical return on investment (ROI) values for AstraZeneca (AZN) over the last 10 years.

AstraZeneca ROI - Return on Investment Historical Data
Date	TTM Net Income	LT Investments & Debt	Return on Investment
2025-09-30	$12.80B	$70.67B	18.59%
2025-06-30	$11.32B	$69.52B	16.51%
2025-03-31	$10.56B	$67.82B	15.55%
2024-12-31	$10.00B	$67.38B	14.89%
2024-09-30	$9.20B	$69.69B	14.00%
2024-06-30	$9.05B	$66.82B	14.33%
2024-03-31	$8.76B	$64.76B	14.16%
2023-12-31	$8.19B	$61.53B	13.35%
2023-09-30	$8.05B	$59.45B	13.21%
2023-06-30	$7.35B	$61.75B	12.11%
2023-03-31	$5.43B	$62.73B	8.92%
2022-12-31	$3.76B	$60.02B	6.13%
2022-09-30	$2.37B	$58.17B	3.76%
2022-06-30	$-0.55B	$62.41B	-0.84%
2022-03-31	$0.04B	$64.44B	0.07%
2021-12-31	$1.06B	$67.42B	2.04%
2021-09-30	$2.84B	$68.12B	6.56%
2021-06-30	$5.68B	$39.80B	16.62%
2021-03-31	$5.84B	$31.86B	18.57%
2020-12-31	$5.16B	$33.14B	16.97%
2020-09-30	$4.25B	$31.89B	14.31%
2020-06-30	$3.84B	$28.81B	13.02%
2020-03-31	$3.05B	$27.85B	10.03%
2019-12-31	$2.92B	$30.33B	9.51%
2019-09-30	$3.42B	$30.89B	11.04%
2019-06-30	$3.52B	$32.43B	11.25%
2019-03-31	$3.79B	$29.35B	12.38%
2018-12-31	$3.39B	$31.40B	10.98%
2018-09-30	$3.00B	$31.96B	9.65%
2018-06-30	$3.29B	$29.72B	10.58%
2018-03-31	$3.46B	$30.26B	10.88%
2017-12-31	$3.68B	$32.20B	11.66%
2017-09-30	$5.52B	$32.36B	17.67%
2017-06-30	$5.40B	$32.20B	17.66%
2017-03-31	$4.78B	$29.34B	15.67%
2016-12-31	$4.90B	$31.17B	15.87%
2016-09-30	$3.46B	$29.66B	11.06%
2016-06-30	$3.60B	$31.91B	11.90%
2016-03-31	$4.22B	$30.79B	14.59%
2015-12-31	$4.11B	$32.65B	14.94%
2015-09-30	$2.68B	$25.64B	10.15%
2015-06-30	$2.05B	$26.60B	7.59%
2015-03-31	$2.23B	$25.23B	8.06%
2014-12-31	$2.14B	$28.04B	7.45%
2014-09-30	$1.90B	$27.99B	6.40%
2014-06-30	$3.06B	$29.63B	9.99%
2014-03-31	$3.15B	$29.03B	10.10%
2013-12-31	$3.71B	$31.84B	11.64%
2013-09-30	$6.27B	$32.01B	19.42%
2013-06-30	$6.72B	$31.92B	20.88%
2013-03-31	$7.39B	$31.81B	23.39%
2012-12-31	$8.15B	$33.36B	26.37%
2012-09-30	$8.35B	$31.60B	27.60%
2012-06-30	$10.46B	$29.54B	34.57%
2012-03-31	$11.55B	$29.09B	37.13%
2011-12-31	$12.80B	$30.80B	40.27%
2011-09-30	$13.46B	$31.55B	41.80%
2011-06-30	$11.60B	$33.03B	36.03%
2011-03-31	$11.50B	$31.71B	36.21%
2010-12-31	$11.49B	$32.51B	36.69%
2010-09-30	$11.63B	$31.54B	37.89%
2010-06-30	$12.37B	$31.31B	40.87%
2010-03-31	$12.04B	$29.94B	40.85%
2009-12-31	$11.54B	$29.96B	40.70%
2009-09-30	$10.38B	$29.84B	37.61%
2009-06-30	$9.62B	$28.11B	35.81%
2009-03-31	$9.38B	$25.54B	35.27%
2008-12-31	$8.62B	$26.92B	32.32%
2008-09-30	$14.99B	$26.93B	56.88%
2008-06-30	$19.75B	$27.01B	100.65%
2008-03-31	$19.20B	$25.84B	113.94%
2007-12-31	$19.09B	$25.65B	135.05%
2007-09-30	$12.24B		103.55%
2007-06-30	$7.07B	$15.90B	44.87%
2007-03-31	$7.26B	$14.99B	46.04%
2006-12-31	$7.13B	$16.39B	45.41%
2006-09-30	$7.38B	$15.77B	48.28%
2006-06-30	$7.05B	$15.96B	47.20%
2006-03-31	$6.80B	$14.70B	46.51%
2005-12-31	$6.31B	$14.71B	43.19%
2005-09-30	$6.29B	$14.40B	42.47%
2005-06-30	$5.84B	$14.64B	52.04%
2005-03-31	$5.14B	$14.66B	46.29%
2004-12-31	$4.77B	$15.55B	64.07%
2004-09-30	$4.00B		57.75%
2004-06-30	$3.83B	$14.23B	55.31%
2004-03-31	$3.69B		55.73%
2003-12-31	$3.91B	$13.48B	40.10%
2003-09-30	$4.03B		43.57%
2003-06-30	$3.92B	$13.02B	31.96%
2003-03-31	$4.09B	$12.52B	34.51%
2002-12-31	$3.98B	$11.50B	45.56%
2002-09-30	$3.39B	$12.07B	40.06%
2002-06-30	$3.39B	$11.33B	62.22%
2002-03-31	$3.33B		64.47%
2001-12-31	$3.08B	$10.46B	59.69%
2001-09-30	$6.91B		135.60%
2001-06-30	$10.28B	$10.20B	201.88%
2001-03-31	$13.30B		523.07%
2000-12-31	$17.01B	$10.17B	668.71%
2000-06-30	$13.11B		304.48%
2000-03-31	$12.95B		300.62%
1998-12-31	$15.40B	$4.93B	1249.15%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$290.389B	$54.073B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$175.297B	14.89
Gilead Sciences (GILD)	United States	$152.107B	14.97
Vertex Pharmaceuticals (VRTX)	United States	$116.860B	30.08
Bristol Myers Squibb (BMY)	United States	$113.534B	8.50
GSK (GSK)	United Kingdom	$102.715B	11.38
Regeneron Pharmaceuticals (REGN)	United States	$80.716B	20.94
CSL (CSLLY)	Australia	$57.025B	0.00
Argenex SE (ARGX)	Netherlands	$49.009B	60.86
Alnylam Pharmaceuticals (ALNY)	United States	$49.002B	1612.65
Insmed (INSM)	United States	$35.770B	0.00
Biogen (BIIB)	United States	$27.232B	11.09
Royalty Pharma (RPRX)	United States	$23.240B	8.91
BioNTech SE (BNTX)	Germany	$23.009B	0.00
Revolution Medicines (RVMD)	United States	$22.651B	0.00
Illumina (ILMN)	United States	$22.240B	33.38
Genmab (GNMSF)	Denmark	$22.108B	16.22
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$21.812B	0.00
Genmab (GMAB)	Denmark	$21.809B	16.40
Incyte (INCY)	United States	$20.875B	19.99
Exact Sciences (EXAS)	United States	$19.507B	538.05
Roivant Sciences (ROIV)	United Kingdom	$15.412B	0.00
Guardant Health (GH)	United States	$13.558B	0.00
Moderna (MRNA)	United States	$13.222B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.024B	24.23
Ascendis Pharma (ASND)	Denmark	$12.938B	0.00
Exelixis (EXEL)	United States	$11.813B	18.91
BioMarin Pharmaceutical (BMRN)	United States	$11.087B	20.11
Avidity Biosciences (RNA)	United States	$10.901B	0.00
Bio-Techne Corp (TECH)	United States	$10.371B	38.70
QIAGEN (QGEN)	Netherlands	$9.978B	18.94
Jazz Pharmaceuticals (JAZZ)	Ireland	$9.946B	38.79
Repligen (RGEN)	United States	$9.479B	101.45
Abivax SA (ABVX)	France	$9.196B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$8.959B	0.00
Axsome Therapeutics (AXSM)	United States	$8.914B	0.00
Halozyme Therapeutics (HALO)	United States	$8.516B	13.61
Bio-Rad Laboratories (BIO.B)	United States	$8.381B	30.14
Cytokinetics (CYTK)	United States	$7.903B	0.00
Krystal Biotech (KRYS)	United States	$7.891B	40.80
Nuvalent (NUVL)	United States	$7.210B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$7.000B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Praxis Precision Medicines (PRAX)	United States	$6.947B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
PTC Therapeutics (PTCT)	United States	$6.230B	8.46
Vaxcyte (PCVX)	United States	$6.001B	0.00
Belite Bio (BLTE)	United States	$5.807B	0.00
Apogee Therapeutics (APGE)	United States	$5.305B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.270B	0.00
Kymera Therapeutics (KYMR)	United States	$5.259B	0.00
Anbio Biotechnology (NNNN)	Germany	$5.135B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.017B	129.44
Cogent Biosciences (COGT)	United States	$4.949B	0.00
Alkermes (ALKS)	Ireland	$4.891B	14.38
Celcuity (CELC)	United States	$4.836B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$4.600B	0.00
Immunovant (IMVT)	United States	$4.524B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.511B	4.57
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.499B	37.99
Scholar Rock Holding (SRRK)	United States	$4.443B	0.00
Amicus Therapeutics (FOLD)	United States	$4.406B	357.00
TG Therapeutics (TGTX)	United States	$4.401B	9.97
Legend Biotech (LEGN)	United States	$4.377B	0.00
CG Oncology (CGON)	United States	$4.333B	0.00
ADMA Biologics Inc (ADMA)	United States	$4.267B	30.39
Structure Therapeutics (GPCR)	United States	$4.209B	0.00
GRAIL (GRAL)	United States	$4.129B	0.00
Ligand Pharmaceuticals (LGND)	United States	$4.070B	99.91
Arcellx (ACLX)	United States	$3.751B	0.00
Viking Therapeutics (VKTX)	United States	$3.590B	0.00
Beam Therapeutics (BEAM)	United States	$3.419B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.280B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.230B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.206B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.186B	0.00
Liquidia (LQDA)	United States	$3.184B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.117B	91.38
Viridian Therapeutics (VRDN)	United States	$3.109B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.073B	0.00
Travere Therapeutics (TVTX)	United States	$3.051B	0.00
Disc Medicine (IRON)	United States	$2.983B	0.00
Vera Therapeutics (VERA)	United States	$2.970B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.935B	74.84
Adaptive Biotechnologies (ADPT)	United States	$2.788B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.649B	0.00
Denali Therapeutics (DNLI)	United States	$2.633B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.610B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.605B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.558B	0.00
Edgewise Therapeutics (EWTX)	United States	$2.555B	0.00
ImmunityBio (IBRX)	United States	$2.551B	0.00
Spyre Therapeutics (SYRE)	United States	$2.545B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$2.500B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.445B	6.64
Mesoblast (MESO)	Australia	$2.395B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.351B	0.00
Twist Bioscience (TWST)	United States	$2.331B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.326B	0.00
Arcus Biosciences (RCUS)	United States	$2.300B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.215B	0.00
Nuvation Bio (NUVB)	United States	$2.215B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.204B	12.03
Alumis (ALMS)	United States	$2.202B	0.00
Zai Lab (ZLAB)	China	$2.059B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.977B	0.00
Maze Therapeutics (MAZE)	United States	$1.934B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.895B	14.69
Immunome (IMNM)	United States	$1.886B	0.00
Vericel (VCEL)	United States	$1.851B	152.46
Dynavax Technologies (DVAX)	United States	$1.841B	54.07
Syndax Pharmaceuticals (SNDX)	United States	$1.801B	0.00
MannKind (MNKD)	United States	$1.772B	57.70
Erasca (ERAS)	United States	$1.768B	0.00
Zymeworks (ZYME)	United States	$1.733B	0.00
Upstream Bio (UPB)	United States	$1.711B	0.00
Celldex Therapeutics (CLDX)	United States	$1.706B	0.00
Fortrea Holdings (FTRE)	United States	$1.700B	36.08
Stoke Therapeutics (STOK)	United States	$1.680B	43.91
Dianthus Therapeutics (DNTH)	United States	$1.677B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.651B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.649B	0.00
MBX Biosciences (MBX)	United States	$1.638B	0.00
Sionna Therapeutics (SION)	United States	$1.622B	0.00
NeoGenomics (NEO)	United States	$1.616B	0.00
NovoCure (NVCR)	Jersey	$1.588B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.545B	74.12
Tyra Biosciences (TYRA)	United States	$1.536B	0.00
Certara (CERT)	United States	$1.496B	27.62
Kodiak Sciences (KOD)	United States	$1.489B	0.00
Alvotech (ALVO)	Luxembourg	$1.486B	21.43
Precigen (PGEN)	United States	$1.463B	0.00
Trevi Therapeutics (TRVI)	United States	$1.448B	0.00
Tango Therapeutics (TNGX)	United States	$1.436B	0.00
UniQure (QURE)	Netherlands	$1.435B	0.00
Nurix Therapeutics (NRIX)	United States	$1.413B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.367B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.366B	0.00
Pharvaris (PHVS)	Netherlands	$1.365B	0.00
AnaptysBio (ANAB)	United States	$1.358B	0.00
AbCellera Biologics (ABCL)	Canada	$1.353B	0.00
Intellia Therapeutics (NTLA)	United States	$1.324B	0.00
EyePoint (EYPT)	United States	$1.320B	0.00
Rapport Therapeutics (RAPP)	United States	$1.287B	0.00
Pharming Group (PHAR)	Netherlands	$1.287B	0.00
Novavax (NVAX)	United States	$1.259B	3.20
Biohaven (BHVN)	United States	$1.253B	0.00
Sana Biotechnology (SANA)	United States	$1.220B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.212B	0.00
Palvella Therapeutics (PVLA)	United States	$1.189B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.163B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.162B	0.00
Castle Biosciences (CSTL)	United States	$1.158B	158.64
Septerna (SEPN)	United States	$1.114B	0.00
Immatics (IMTX)	Germany	$1.113B	0.00
Pharming Group (PHGUF)	Netherlands	$1.107B	165.00
Inhibrx Biosciences (INBX)	United States	$1.104B	0.00
Zenas BioPharma (ZBIO)	United States	$1.062B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.058B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$1.033B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$1.013B	0.00
Urogen Pharma (URGN)	United States	$1.004B	0.00
Ventyx Biosciences (VTYX)	United States	$0.988B	0.00
Pacira BioSciences (PCRX)	United States	$0.986B	11.30
Nanobiotix S.A - (NBTX)	France	$0.971B	0.00
Bicara Therapeutics (BCAX)	United States	$0.955B	0.00
Rapt Therapeutics (RAPT)	United States	$0.953B	0.00
Iovance Biotherapeutics (IOVA)	United States	$0.953B	0.00
Compass Therapeutics (CMPX)	United States	$0.927B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Geron (GERN)	United States	$0.913B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
Oric Pharmaceuticals (ORIC)	United States	$0.891B	0.00
MiMedx (MDXG)	United States	$0.889B	15.79
Arbutus Biopharma (ABUS)	United States	$0.865B	0.00
MapLight Therapeutics (MPLT)	United States	$0.865B	0.00
Janux Therapeutics (JANX)	United States	$0.844B	0.00
ArriVent BioPharma (AVBP)	United States	$0.844B	0.00
YD Bio (YDES)		$0.834B	0.00
Vir Biotechnology (VIR)	United States	$0.824B	0.00
Kura Oncology (KURA)	United States	$0.798B	0.00
Inventiva S.A (IVA)	France	$0.795B	0.00
GH Research (GHRS)	Ireland	$0.791B	0.00
Arvinas (ARVN)	United States	$0.780B	0.00
Prime Medicine (PRME)	United States	$0.773B	0.00
REGENXBIO (RGNX)	United States	$0.763B	0.00
Gyre Therapeutics (GYRE)	United States	$0.742B	96.25
Cytek Biosciences (CTKB)	United States	$0.742B	0.00
CytomX Therapeutics (CTMX)	United States	$0.735B	10.85
Astria Therapeutics (ATXS)	United States	$0.726B	0.00
DBV Technologies S.A (DBVT)	France	$0.720B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.690B	0.00
Jade Biosciences (JBIO)	United States	$0.684B	0.00
Evommune (EVMN)	United States	$0.666B	0.00
Annexon (ANNX)	United States	$0.665B	0.00
Emergent Biosolutions (EBS)	United States	$0.651B	6.26
Sinovac Biotech (SVA)	China	$0.645B	0.00
BioAge Labs (BIOA)	United States	$0.640B	0.00
Replimune (REPL)	United States	$0.636B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.627B	0.00
Myriad Genetics (MYGN)	United States	$0.612B	0.00
SELLAS Life Sciences (SLS)	United States	$0.585B	0.00
Gossamer Bio (GOSS)	United States	$0.583B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.583B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.579B	0.00
Keros Therapeutics (KROS)	United States	$0.575B	12.26
Invivyd (IVVD)	United States	$0.571B	0.00
CorMedix Inc (CRMD)	United States	$0.563B	5.22
EnGene Holdings (ENGN)	Canada	$0.556B	0.00
Ocugen (OCGN)	United States	$0.556B	0.00
Alto Neuroscience (ANRO)	United States	$0.526B	0.00
Design Therapeutics (DSGN)	United States	$0.520B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.515B	0.00
Absci (ABSI)	United States	$0.511B	0.00
Niagen Bioscience (NAGE)	United States	$0.510B	39.94
Corvus Pharmaceuticals (CRVS)	United States	$0.504B	0.00
LENZ Therapeutics (LENZ)	United States	$0.487B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.481B	0.00
Prothena (PRTA)	Ireland	$0.480B	0.00
Verastem (VSTM)	United States	$0.475B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.473B	0.00
Kamada (KMDA)	Israel	$0.463B	22.39
Bicycle Therapeutics (BCYC)	United Kingdom	$0.456B	0.00
Prima BioMed (IMMP)	Australia	$0.452B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.438B	0.00
Monopar Therapeutics (MNPR)	United States	$0.435B	0.00
PureTech Health (PRTC)	United States	$0.431B	0.00
NovaBridge Biosciences (NBP)	United States	$0.429B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.429B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.425B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.424B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.415B	0.00
Benitec Biopharma (BNTC)	United States	$0.411B	0.00
Solid Biosciences (SLDB)	United States	$0.408B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.399B	0.00
PepGen (PEPG)	United States	$0.390B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.390B	0.00
Anavex Life Sciences (AVXL)	United States	$0.383B	0.00
Entrada Therapeutics (TRDA)	United States	$0.380B	0.00
Allogene Therapeutics (ALLO)	United States	$0.375B	0.00
BGM Group (BGM)	China	$0.373B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.373B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.372B	0.00
Forte Biosciences (FBRX)	United States	$0.372B	0.00
Neumora Therapeutics (NMRA)	United States	$0.371B	0.00
Tectonic Therapeutic (TECX)	United States	$0.367B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.361B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.360B	0.00
AC Immune (ACIU)	Switzerland	$0.353B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.341B	0.00
Zura Bio (ZURA)	United States	$0.336B	0.00
XOMA Royalty (XOMA)	United States	$0.332B	0.00
Amarin (AMRN)	Ireland	$0.324B	0.00
Aardvark Therapeutics (AARD)	United States	$0.323B	0.00
Aura Biosciences (AURA)	United States	$0.322B	0.00
Candel Therapeutics (CADL)	United States	$0.322B	0.00
Climb Bio (CLYM)	United States	$0.320B	0.00
Puma Biotechnology (PBYI)	United States	$0.316B	8.49
GENFIT S.A (GNFTY)	France	$0.310B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.295B	0.00
Shattuck Labs (STTK)	United States	$0.290B	0.00
Lifecore Biomedical (LFCR)	United States	$0.284B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.283B	0.00
Palisade Bio (PALI)	United States	$0.283B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.282B	0.00
Abeona Therapeutics (ABEO)	United States	$0.276B	4.51
Immuneering (IMRX)	United States	$0.272B	0.00
Jyong Biotech (MENS)	Taiwan	$0.271B	0.00
Neurogene (NGNE)	United States	$0.268B	0.00
Contineum Therapeutics (CTNM)	United States	$0.268B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.266B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.263B	0.00
Adherex Technologies (FENC)	United States	$0.260B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.252B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.251B	0.00
Rezolute (RZLT)	United States	$0.233B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Alpha Teknova (TKNO)	United States	$0.222B	0.00
Voyager Therapeutics (VYGR)	United States	$0.217B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.214B	0.00
Cabaletta Bio (CABA)	United States	$0.213B	0.00
Humacyte (HUMA)	United States	$0.212B	0.00
Nuvectis Pharma (NVCT)	United States	$0.210B	0.00
Editas Medicine (EDIT)	United States	$0.208B	0.00
C4 Therapeutics (CCCC)	United States	$0.206B	0.00
Sagimet Biosciences (SGMT)	United States	$0.203B	0.00
Alector (ALEC)	United States	$0.201B	0.00
Coherus Oncology (CHRS)	United States	$0.199B	0.00
Cardiff Oncology (CRDF)	United States	$0.193B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.189B	0.00
Cybin (HELP)	Canada	$0.186B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.181B	0.00
SAB Biotherapeutics (SABS)	United States	$0.178B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.177B	0.00
Compugen (CGEN)	Israel	$0.177B	0.00
Innate Pharma S.A (IPHA)	France	$0.171B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.168B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.167B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.165B	0.00
Quince Therapeutics (QNCX)	United States	$0.164B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.160B	0.00
Nkarta (NKTX)	United States	$0.155B	0.00
Crescent Biopharma (CBIO)	United States	$0.153B	0.00
Codexis (CDXS)	United States	$0.152B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.151B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.150B	7.33
Immix Biopharma (IMMX)	United States	$0.149B	0.00
Caribou Biosciences (CRBU)	United States	$0.148B	0.00
Vor Biopharma (VOR)		$0.147B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
MaxCyte (MXCT)	United States	$0.145B	0.00
Agenus (AGEN)	United States	$0.145B	0.00
Seres Therapeutics (MCRB)	United States	$0.143B	0.00
Spero Therapeutics (SPRO)	United States	$0.141B	0.00
Opus Genetics (IRD)	United States	$0.141B	0.00
Anika Therapeutics (ANIK)	United States	$0.136B	0.00
Elicio Therapeutics (ELTX)	United States	$0.135B	0.00
VTv Therapeutics (VTVT)	United States	$0.134B	0.00
Actuate Therapeutics (ACTU)	United States	$0.134B	0.00
Alpha Cognition (ACOG)	Canada	$0.132B	0.00
Fortress Biotech (FBIO)	United States	$0.130B	0.00
Cognition Therapeutics (CGTX)	United States	$0.130B	0.00
Turn Therapeutics (TTRX)	United States	$0.125B	0.00
Fate Therapeutics (FATE)	United States	$0.123B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.123B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.121B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.120B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.119B	0.00
Ovid Therapeutics (OVID)	United States	$0.115B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.114B	0.00
Scilex Holding (SCLX)	United States	$0.114B	0.00
Tharimmune (THAR)	United States	$0.113B	0.00
Repare Therapeutics (RPTX)	Canada	$0.111B	0.00
Seer (SEER)	United States	$0.109B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.109B	0.00
OKYO Pharma (OKYO)		$0.108B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.105B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.104B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.104B	0.00
Biomea Fusion (BMEA)	United States	$0.103B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.103B	0.00
Genelux (GNLX)	United States	$0.101B	0.00
Coya Therapeutics (COYA)	United States	$0.099B	0.00
Sutro Biopharma (STRO)	United States	$0.096B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Tenax Therapeutics (TENX)	United States	$0.092B	0.00
Annovis Bio (ANVS)	United States	$0.091B	0.00
Citius Oncology (CTOR)	United States	$0.091B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.090B	0.00
BioStem Technologies (BSEM)		$0.089B	6.24
Spruce Biosciences (SPRB)	United States	$0.083B	0.00
BioHarvest Sciences (BHST)	Canada	$0.083B	0.00
Pliant Therapeutics (PLRX)	United States	$0.082B	0.00
EXoZymes (EXOZ)	United States	$0.080B	0.00
Immunic (IMUX)	United States	$0.080B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.078B	0.00
CalciMedica (CALC)	United States	$0.078B	0.00
ImageneBio (IMA)	United States	$0.077B	0.00
XBiotech (XBIT)	United States	$0.077B	0.00
Adagene (ADAG)	China	$0.075B	0.00
Adicet Bio (ACET)	United States	$0.075B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.074B	0.00
Entera Bio (ENTX)	Israel	$0.072B	0.00
MediciNova (MNOV)	United States	$0.071B	0.00
CervoMed (CRVO)	United States	$0.070B	0.00
Equillium (EQ)	United States	$0.070B	0.00
InflaRx (IFRX)	Germany	$0.068B	0.00
BeyondSpring (BYSI)	United States	$0.067B	0.00
ATyr Pharma (ATYR)	United States	$0.067B	0.00
TScan Therapeutics (TCRX)	United States	$0.066B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.065B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.062B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.061B	0.00
IBio (IBIO)	United States	$0.061B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.059B	0.00
Passage Bio (PASG)	United States	$0.057B	0.00
MiNK Therapeutics (INKT)	United States	$0.056B	0.00
Clene (CLNN)	United States	$0.056B	0.00
Grace Therapeutics (GRCE)	United States	$0.056B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.055B	0.00
Precision BioSciences (DTIL)	United States	$0.054B	0.00
Aligos Therapeutics (ALGS)	United States	$0.054B	0.00
ABVC BioPharma (ABVC)	United States	$0.051B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
PDS Biotechnology (PDSB)	United States	$0.048B	0.00
NextCure (NXTC)	United States	$0.047B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
Q32 Bio (QTTB)	United States	$0.045B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.044B	0.00
OnKure Therapeutics (OKUR)	United States	$0.043B	0.00
TELA Bio (TELA)	United States	$0.043B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.042B	2.70
Tvardi Therapeutics (TVRD)	United States	$0.042B	0.00
Jasper Therapeutics (JSPR)	United States	$0.041B	0.00
Estrella Immunopharma (ESLA)	United States	$0.040B	0.00
INmune Bio (INMB)	United States	$0.039B	0.00
RenovoRx (RNXT)	United States	$0.038B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.038B	0.00
Lantern Pharma (LTRN)	United States	$0.038B	0.00
Exicure (XCUR)	United States	$0.037B	0.00
Oncobiologics (OTLK)	United States	$0.037B	0.00
TuHURA Biosciences (HURA)	United States	$0.037B	0.00
Medicus Pharma (MDCX)	United States	$0.037B	0.00
IO Biotech (IOBT)	Denmark	$0.036B	0.00
Xilio Therapeutics (XLO)	United States	$0.035B	0.00
Galecto (GLTO)	Denmark	$0.035B	0.00
Femasys (FEMY)	United States	$0.035B	0.00
Dyadic (DYAI)	United States	$0.034B	0.00
Cingulate (CING)	United States	$0.033B	0.00
AN2 Therapeutics (ANTX)	United States	$0.031B	0.00
Pluri (PLUR)	Israel	$0.031B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.031B	0.00
Rallybio (RLYB)	United States	$0.031B	0.00
Rein Therapeutics (RNTX)	United States	$0.030B	0.00
Skye Bioscience (SKYE)	United States	$0.030B	0.00
Senti Biosciences (SNTI)	United States	$0.029B	0.00
Elutia (ELUT)	United States	$0.029B	0.00
Hyperion DeFi (HYPD)	United States	$0.028B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.028B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.028B	0.00
Boundless Bio (BOLD)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Aytu BioPharma (AYTU)	United States	$0.027B	0.00
Cue Biopharma (CUE)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.027B	0.00
Quantum Biopharma (QNTM)	Canada	$0.027B	0.00
FibroBiologics (FBLG)	United States	$0.026B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.025B	0.00
Intensity Therapeutics (INTS)	United States	$0.025B	0.00
Apollomics (APLM)	United States	$0.024B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.023B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.021B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.020B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.019B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.019B	0.00
BioAtla (BCAB)	United States	$0.019B	0.00
Lisata Therapeutics (LSTA)	United States	$0.018B	0.00
Allarity Therapeutics (ALLR)	United States	$0.018B	0.00
MetaVia (MTVA)	United States	$0.018B	0.00
Promis Neurosciences (PMN)	Canada	$0.018B	0.00
Hoth Therapeutics (HOTH)	United States	$0.016B	0.00
Bionano Genomics (BNGO)	United States	$0.016B	0.00
Applied Therapeutics (APLT)	United States	$0.015B	0.00
Cocrystal Pharma (COCP)	United States	$0.015B	0.00
BioCardia (BCDA)	United States	$0.015B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.014B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.014B	0.00
Polyrizon (PLRZ)	Israel	$0.014B	0.00
Black Titan (BTTC)	United States	$0.014B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
Synlogic (SYBX)	United States	$0.013B	0.00
Edesa Biotech (EDSA)	Canada	$0.012B	0.00
Longeveron (LGVN)	United States	$0.012B	0.00
Curis (CRIS)	United States	$0.012B	0.00
NewcelX (NCEL)	Switzerland	$0.011B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.011B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.011B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Abpro Holdings (ABP)	United States	$0.011B	0.00
Novogen (KZIA)	Australia	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.011B	0.00
Biorestorative Therapies (BRTX)	United States	$0.010B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.010B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.010B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.010B	0.00
Biofrontera (BFRI)	United States	$0.009B	0.00
IN8bio (INAB)	United States	$0.009B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
Purple Biotech (PPBT)	Israel	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.008B	0.00
Moleculin Biotech (MBRX)	United States	$0.008B	0.00
GENPREX (GNPX)	United States	$0.008B	0.00
Mustang Bio (MBIO)	United States	$0.008B	0.00
IMMURON (IMRN)	Australia	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.008B	0.00
Advanced Biomed (ADVB)	United States	$0.008B	0.00
Gelteq (GELS)	Australia	$0.007B	0.00
Beyond Air (XAIR)	United States	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.007B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.007B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.006B	0.00
Aprea Therapeutics (APRE)	United States	$0.006B	0.00
KALA BIO (KALA)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.006B	0.00
Evogene (EVGN)	Israel	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Revelation Biosciences (REVB)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
Avalon GloboCare (ALBT)	United States	$0.005B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
HCW Biologics (HCWB)	United States	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.004B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.004B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.004B	0.00
Alps Group (ALPS)	United States	$0.003B	2.94
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Ensysce Biosciences (ENSC)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Onconetix (ONCO)	United States	$0.002B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.002B	0.00
Enveric Biosciences (ENVB)	United States	$0.002B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Psyence Biomedical (PBM)	Canada	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00